JPS Symposium: “Philadelphia Success Stories in Life Sciences”
From left to right: Anthony Gold; Gregory T. Bosch; Paul Touhey; Jennifer Miller; Daniel S. Messina; Wayne Tamarelli, Chair, Joseph Priestley Society; and James A Datin. Photograph by Conrad Erb.
The Eastern Technology Council serves leaders of more than seven hundred technology and life-sciences companies by providing valuable contacts and capital, information and education, through a wide variety of events, publications, and innovative services. The council provides a business culture that embraces start-ups and established companies by promoting, supporting, funding, and rewarding entrepreneurial activities in the region in an effort to encourage growth and successful businesses.
Each year, the Eastern Technology Council gives its Enterprise Awards to companies of distinction in technology and the life sciences. The winners of the 2009 Enterprise Awards in Life Sciences assembled for this Joseph Priestley Society Symposium to discuss the way to find and exploit the best of what Philadelphia has to offer the life-sciences industry.
About the Keynote Speaker
Daniel S. Messina
Executive Vice President, Business Strategy, Health Advocate
Daniel Messina joined Health Advocate in 2006 with more than twenty-five years of financial and business experience. Before joining Health Advocate, Messina was the president and chief operating officer of the Rendina Companies, a real-estate development company headquartered in Florida. Other notable positions include president and CEO of Magellan Health, the nation’s largest managed mental-health company serving seventy million Americans, and chief financial officer and head of business strategy for Aetna U.S. Healthcare. Earlier in his career, Messina worked at CIGNA as vice president for financial reporting and also held finance positions at Springborn Group, Inc., and Deloitte & Touche. Messina received his bachelor’s degree in accounting from the University of Notre Dame.
About the Moderator
James A. Datin
Executive Vice President and Managing Director, Life Sciences Group, Safeguard Scientifics
James Datin has more than twenty years of experience in diagnostic, device, and health-care industries. He joined Safeguard as executive vice president and managing director, Life Sciences Group, in September 2005. Datin is responsible for Safeguard’s investment and partnership opportunities within the health-care industry. He is a board member of Safeguard’s partner companies Cellumen, Inc.; Clarient, Inc.; Molecular Biometrics, Inc.; Quinnova Pharmaceuticals, Inc.; and Rubicor Medical, Inc. He is also a member of Ben Franklin Technology Partner’s advisory board and is on the Celerant Consulting advisory board. Before joining Safeguard, Datin served as chief executive officer of Touchpoint Solutions, Inc.; group director, Corporate Business Strategy and Planning, at GlaxoSmithKline; and chief executive officer of Isuta Holdings Berhad. His previous experience also includes international assignments with and identifying strategic growth opportunities for E. Merck and Baxter.
About the Panelists
CEO, Healthy Humans
Anthony Gold is the CEO of Healthy Humans, a doctor-directed portal that helps people with chronic illness lead healthier lives. Gold is also the president of the Open Solutions Alliance (OSA), a nonprofit global organization focused on addressing the interoperability of open source among business infrastructures. He was also recently chosen to chair the Healthcare Working Group for the Open Source for America coalition. Before this, Gold was the vice president and general manager of the start-up Open Source Business within the $6B Unisys Corporation. Gold serves as a business consultant and board member for several start-ups and nonprofits in the Philadelphia region, including LiquidHub and Bluenog. He sits on the executive committee for the Chester County Healthcare Partnership and is an advisory board member for the Academy in Manayunk, an educational institution for children with learning disabilities. Gold graduated from Drexel University with a B.S. in electrical engineering.
Gregory T. Bosch
CEO, PuriCore (Emerging Life Sciences Company)
Gregory Bosch joined PuriCore in November 2004 as chief executive officer. Before this, Bosch held a variety of management and leadership positions with Baxter International during his nineteen-year tenure, most recently from 1998 to 2004 as vice president and general manager of Baxter’s BioSurgery division. He had international assignments in Austria and Switzerland, and he was a board member of Baxter AG, a company with more than 2,500 employees. In 2006 Bosch was named Life Sciences CEO of the Year by the Eastern Technology Council’s Enterprise Awards for the Greater Philadelphia region. He received his B.A. from Duke University and his M.B.A. from DePaul University.
President/CEO, Fujirebio Diagnostics, Inc. (Life Sciences Company of the Year)
Paul Touhey is the president and CEO and a member of the board of directors of Fujirebio Diagnostics, Inc. (FDI), the world’s premier cancer diagnostics company. He is also a member of the board of directors of Fujirebio Inc., the Tokyo-based parent of FDI. Touhey joined FDI, formerly Centocor Diagnostics, in 1985. Before this, he worked for Johnson & Johnson in a variety of positions. Touhey is past chairman and a current member of the board of the Medical Device Manufacturers Association, a national trade association representing the entrepreneurial sector of the medical-device industry in the United States, and is a member of the FDA/Industry Grass Roots Task Force and the Board of the Pennsylvania Bio Association. Touhey established the Companies of Caring Campaign with the Community Volunteers in Medicine, a Chester County charity focusing on providing medical care to the uninsured. He is a member of the board of directors for both the Freedom Valley YMCA and Orthovita, Inc., a publicly traded orthobiologics company. Touhey received his B.A. in political science from Temple University.